Efficacy and Safety Study of CC-5013 Monotherapy in Subjects With Myelodysplastic Syndromes
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Robert Knight, MD
Celgene Corporation
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
119 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Royal Adelaide Hospital - Sa Pathology Haematology
Adelaide, South Australia, Australia
- Princess Alexandra Hospital - Haematology
Brisbane, Australia
- Royal Prince Alfred Hospital - Institute of Haematology
Camperdown, Australia
- Peter Mccallum Cancer Institute - Directorate of Cancer Medecine
East Melbourne, Australia
- Frankston Hospital-Peninsula Health - Oncology Day Unit
Frankston, Australia
- the Alfred Hospital - Malignant Haematology & Stem Cell Transplantation
Melbourne, Australia
- Calvary Mater Newcastle - Haematology
Waratah, Australia
- Border Medical Oncology
Wodonga, Australia
- Wollongong Hospital - Haematology
Wollongong, Australia
- Uz Gent - Hematology
Ghent, Belgium
- University Hospital Leuven - Hematology
Leuven, Belgium
- Cliniques Universitaires Ulc de Mont-Godinne - Hematology
Yvoir, Belgium
- Fakultní Nemocnice Hradec Králové - Hematology
Hradec Králové, Czechia
- Charles University Hospital - Internal Medicine
Prague, Czechia
- Aalborg Sygemus - Haematology
Aalborg, Denmark
- Aarhus University Hospital
Aarhus, Denmark
- Odense University Hospital
Odense, Denmark
- Vejle Hospital - Hematology
Vejle, Denmark
- Chu Angers - Service Des Maladies Du Sang
Angers, France
- Centre Hospitalier de la Côte Basque - Hematologie
Bayonne, France
- Centre Hospitalier Départemental Vendée - Onco-Hematologie
La Roche-sur-Yon, France
- Chru de Lille - Service Des Maladies Du Sang
Lille, France
- Institut Paoli Calmette - Hematology 1
Marseille, France
- Chu Hôtel-Dieu - Hematologie
Nantes, France
- Chu Saint Antoine - Service Des Maladies Du Sang
Paris, France
- Hôpital Saint Louis - Immuno-Hematologie
Paris, France
- Chru - Hôpital Du Haut Lévêque - Centre François Magendie
Pessac, France
- Centre Hospitalier Lyon Sud - Hematologie
Pierre-Bénite, France
- Chru Hôpital Purpan - Hematologie
Toulouse, France
- Hôpital Bretonneau - Hématologie & Thérapie Cellulaire
Tours, France
- Chu Nancy - Hematologie
Vandœuvre-lès-Nancy, France
- Universitätsklinikum Essen, Klinik Für Hämatologie
Essen, Germany
- Universitätsklinikum Heidelberg - Medizinische Klinik Und Poliklinik V
Heidelberg, Germany
- Universitätsklinikum Jena - Klinik Fur Innere Medizin Ii-Hamatologie/onkologie
Jena, Germany
- Universitätsklinikum Leipzig - Medizinische Klinik Und Poliklinik Ii
Leipzig, Germany
- Universitätsklinikum Münster - Medizinische Klinik Und Poliklinik A
Münster, Germany
- Universitätsklinikum Tübingen - Medizinische Klinik Und Poliklinik - Abteilung Ii
Tübingen, Germany
- Universitätsklinikum Ulm - Klinik Fur Innere Medizin Iii
Ulm, Germany
- Universitätsklinikum Würzburg - Medizinische Klinik Und Poliklinik Ii
Würzburg, Germany
- University of Athens - Alexandra Hospital; Clinical Therapeutics
Athens, Greece
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Jun 2003
- Primary completion
- 31 Jan 2007
- Completion
- 28 Feb 2007
- Last update posted
- 4 Apr 2013
- Registered enrollment
- 215
- Registry id
- NCT00064974
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.